Azienda ospedaliero-universitaria San Luigi Gonzaga di Orbassano (Torino)

Borsa di studio dal titolo:“Non-interventional Post-Authorization Safety Study (PASS) to Prospectively Evaluate Rebif New Formulation Safety and Tolerability Profile In Treatment of Naïve Relapsing Sclerosin Patients”.

Testo del documento